Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04576923 · ClinicalTrials.gov registry record · NA
Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT04576923 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 36 participants.
The verdict
NCT04576923, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to prospectively evaluate the utility of Liver Incytes in assessing NAFLD with or without advanced fibrosis in patients seen in liver clinics for suspected NAFLD diagnosis.
Interventions
- DIAGNOSTIC_TEST Velacur by Sonic Incytes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-03-19 |
| Est. Completion | 2022-04-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04576923
The ClinicalTrials.gov registry entry for NCT04576923 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Velacur by Sonic Incytes is the first listed.
NCT04576923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04576923 about?
NCT04576923 is a clinical study titled "Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease". The purpose of this study is to prospectively evaluate the utility of Liver Incytes in assessing NAFLD with or without advanced fibrosis in patients seen in liver clinics for suspected NAFLD diagnosis.
What is the current status of trial NCT04576923?
This trial is currently terminated. It is a NA study. The enrollment target is 36 participants. The study started on 2021-03-19. Estimated completion is 2022-04-26.
What interventions are being tested in trial NCT04576923?
The interventions under investigation include: Velacur by Sonic Incytes (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04576923?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.